IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
IN- VITRO AND IN-VIVO POTENTIAL OF ADENIUM OBESUM FLOWER EXTRACTS INDIABETIC CHALLANGED RAT MODEL

Author: SIREESHA KALVA1*, RAGHUNANDAN N
Abstract: Diabetes mellitus is one of the wide spread and severe metabolic disorder in humans all over the world. Various medicinal plants have effectively been used to conquer this health problem. Adenium obesumcommonly known as desert rose belongs to the family Apocyanacea. The present study was designed to evaluate the in-vivo and in-vitro antidiabetic potential of Adenium obesumflowers in streptozotocin induced diabetic rats.Diabetes was induced by giving streptozotocin intraperitoneally(35-50mg/kg). The methanolic(MEAO) and ehtyl acetate (EAEAO) extracts of Adenium obesumflowers were administered at a dose of 100,200,300 mg/kg each orally.The in-vitro alpha-amylase inhibitory activity of MEAO and EAEAO was done by spectrophotometric method.Acarbose was taken as a standard drug .The invivo anti-hyperglycemic activity was evaluated by estimation of blood glucose levels by glucose–oxidase method and serum insulin was estimated bychemiluminescence assay. Metformin was administered as standard drug at a dose of 50mg/kg.Boththe extracts of Adenium obesumflowers have shown a very strong alpha-amylase inhibitory activityin a dose dependent manner. Both the extracts administered at different doses have shown significant reduction in the bloodglucose levels (p<0.0001) when compared to the diabetic group. A significant increase in the serum insulin (p<0.0001) was also observed with both the extracts in diabetic groups. The results suggested that Adenium obesumflowers extracts may have potent anti-diabetic activity, justifying the use of the drug for the treatment of diabetes mellitus.
Keyword: Adenium obesum, Streptozotocin, Acarabose, Alpha-amylase.
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events

2017: 6.457
2016: 5.999
2015: 5.406
2014: 5.099

CiteScore 2016 -  0.09

SJR 2016 - 0.111

SNIP 2016 - 0.055

Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477
Impact Factor for five years is 1.3 (2010 - 2014)